PSNL Receives Expanded Medicare Coverage for NeXT Personal Test in Triple-Negative and HER2+ Breast Cancer Treatment Monitoring
Personalis, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $11.26
+12% in 3d after detection
Post-detection moves
1h
—
1d
+3.8%
3d
+12%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS